These findings further confirmed the importance of both the PI3K-Akt-mTOR pathway and autophagy in the pathogenesis in IPF, but also give insight into potential novel therapeutic targets in these pathways. This evidence concerns the gene MTOR and idiopathic pulmonary fibrosis.